Listen here:

FULL INFORMATION ON CAPU THERAPY ON www.ItalianRadioinFlorida.com/capu

Personalized and Precision Medicine: Exploring Hyperthermia and Pharmacometabolomics

Source 1: A Case of Personalized and Precision Medicine: Pharmacometabolomic Applications to Rare Cancer, Microbiological Investigation, and Therapy

I. Abstract

This section summarizes the article’s purpose, which is to illustrate how metabolomics, combined with genetic analysis, can inform personalized medicine, particularly in cases involving rare diseases and immunosuppression. It highlights the use of mass spectrometry in identifying metabolic disorders and developing tailored treatment plans.

II. Methods

This section details the application of metabolomic database matching and mass spectrometry to pinpoint molecular factors linked to the patient’s specific metabolic disorder. It emphasizes the development of a personalized and effective therapeutic protocol based on this analysis.

Source 2: C.A.Pu Therapy – Complementary, Reducing, Anti-Degenerative, designed by researcher Puccio – Italian RadioTV in Florida

I. C.A.Pu Therapy Overview

This section introduces C.A.Pu therapy, a complementary treatment approach focused on rebalancing the biochemical system and activating the body’s self-healing mechanisms. It highlights the therapy’s purported benefits, including antiviral and antibacterial effects, restoration of the cellular redox system, and mitigation of drug resistance in bacteria.

II. Micro Liposomal Oral CAPU Therapy

This section focuses on a specific form of C.A.Pu therapy delivered orally using micro liposomal technology. It emphasizes the therapy’s ability to bypass the digestive system and rapidly enter the bloodstream, making it suitable for individuals who cannot tolerate IV administration.

III. Patient Testimonials

This section comprises a collection of anecdotal accounts from individuals who have reportedly benefited from C.A.Pu therapy. Testimonials describe a range of conditions, including COVID-19, rheumatoid arthritis, and various adverse events, showcasing the perceived positive impacts of the therapy.

IV. Scientific Basis and Medical Disclaimer

This section provides links to research articles and videos related to the immune system and neoplastic cells, emphasizing the importance of scientific evidence in healthcare. It also includes a medical disclaimer, stressing the necessity of consulting a qualified healthcare professional for treatment and supplementation decisions.

Source 3: Hyperthermia as an Immunotherapy Strategy for Cancer

I. Introduction

This section establishes the historical context of hyperthermia in medicine, tracing its use back to ancient times and highlighting its renewed interest in cancer treatment. It introduces the concept of hyperthermia as distinct from fever and its potential synergy with immunotherapy.

II. Hyperthermia-Induced Hsps as Modulators of the Immune System

This section delves into the role of heat shock proteins (Hsps) as stress-induced molecules with crucial cellular functions, particularly in the context of cancer and the immune system. It explores the multifaceted nature of Hsps in tumor cells, noting their potential to both promote and inhibit tumor growth. The section emphasizes the ability of Hsps released from stressed cells to activate dendritic cells (DCs), leading to enhanced antigen presentation and T cell activation.

III. Hsps as Cancer Vaccines

This section explores the development of Hsp-peptide complexes as potential cancer vaccines, leveraging their ability to chaperone tumor antigens and activate DCs. It discusses preclinical and clinical trials involving Hsp-based vaccines, noting their potential for personalized cancer treatment.

IV. Improvement of Dendritic Cell and NK-Cell Function by Hyperthermia

This section focuses on the synergistic effects of hyperthermia and immunotherapy, particularly in enhancing DC and NK-cell function. It explores preclinical and clinical studies demonstrating the potential of combining hyperthermia with DC-based cancer vaccines to boost antitumor immune responses. The section also examines the potential of hyperthermia to overcome tumor-induced immune tolerance by promoting DC maturation and inhibiting immunosuppressive cell populations.

Source 4: Liposomal TRPC Glutathione: A Conversation with Dr. Cappelletto

I. Origins and Inspiration

This section traces the development of liposomal TRPC glutathione, highlighting the influence of traditional medicine and collaboration with other researchers. Dr. Cappelletto emphasizes his aim to create an oral alternative to C.A.Pu therapy, particularly for individuals unable to receive IV treatment.

II. Unique Delivery System and Mechanism of Action

This section focuses on the distinctive micro liposomal technology employed in delivering TRPC glutathione. Dr. Cappelletto explains how the small size of the liposomes allows for rapid absorption through mucous membranes, bypassing the digestive system and achieving faster blood circulation compared to conventional liposomal products. He also details the therapy’s effectiveness in detoxification and immune system activation, specifically highlighting the role of phosphatidylethanolamine in cancer and its link to immune function.

III. Nutritional Deficiencies and Their Impact on Health

This section delves into the importance of balanced nutrition and its impact on overall health, particularly focusing on vitamin D deficiency and its connection to iron levels. Dr. Cappelletto underscores the significance of bioavailable vitamins and the challenges of obtaining them through modern diets.

IV. Potential Applications and Benefits

This section highlights the wide-ranging applications of liposomal TRPC glutathione and other Atena Bio products, emphasizing their potential in addressing oxidative stress, inflammation, and various pathologies. Dr. Cappelletto and Fabrizio Ciancio discuss the therapy’s potential as a preventative measure against pandemics and its overall value as an investment in health. The conversation concludes by emphasizing the importance of natural approaches to health and the potential of nutrition in supporting the body’s self-healing mechanisms.

Source 5: CAPU Therapy and the Hippocratic Oath: A Discussion with Dr. Cusumano

I. Introduction and Personal Journey

This section introduces Dr. Cusumano as a family doctor with 40 years of experience and his commitment to the Hippocratic Oath. He shares his experiences during the COVID-19 pandemic, highlighting the limitations of standard protocols and the need for alternative treatment approaches.

II. Challenges with Conventional COVID-19 Protocols

This section focuses on Dr. Cusumano’s critique of the “Tachipirina and vigilant waiting” protocol, emphasizing the negative impact of Tachipirina (acetaminophen) on glutathione levels. He references research from universities in France and Jordan to support his argument, highlighting the crucial role of glutathione in blocking viral replication.